InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Tuesday, 08/21/2018 12:19:36 PM

Tuesday, August 21, 2018 12:19:36 PM

Post# of 108192
I lifted this from the CVM letter to shareholders I found on SA today. I did not investigate the veracity of the quote or the nanes of the companies that were sold but, if true, may bode well for any negotiations Advaxis is conducting:

"In the past 18 months, several successful Phase 3 cancer immunotherapy companies were sold for $7 billion to almost $12 billion. They had positive survival data from their pivotal studies, but had not yet received FDA approval. In addition, recently one cancer immunotherapy company with Phase 3 studies that were not yet complete was sold for about $1.6 billion."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News